DocuSign Inc
SWB:DS3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
DocuSign Inc
SWB:DS3
|
US |
|
Rukun Raharja Tbk PT
IDX:RAJA
|
ID |
|
M
|
Medical Properties Trust Inc
F:M3P
|
US |
|
Creo Medical Group PLC
F:1RC
|
UK |
|
Fugro NV
OTC:FUGRF
|
NL |
|
B
|
Ballard Power Systems Inc
XMUN:PO0
|
CA |
|
H
|
HALEON PLC
F:H6D
|
UK |
|
T
|
TFI International Inc
XBER:9TF
|
CA |
|
Cobra Venture Corp
XTSX:CBV
|
CA |
|
N
|
Neurocrine Biosciences Inc
F:NB3
|
US |
|
B
|
BayWa AG
XMUN:BYW
|
DE |
|
Bank Danamon Indonesia Tbk PT
IDX:BDMN
|
ID |
|
A
|
Atea ASA
XMUN:MKL
|
NO |
|
A
|
Allakos Inc
F:37Z
|
US |
|
H
|
HALEON PLC
XBER:H6D0
|
UK |
Wall St Price Targets
DS3 Price Targets Summary
DocuSign Inc
According to Wall Street analysts, the average 1-year price target for DS3 is 54.66 EUR with a low forecast of 38.88 EUR and a high forecast of 88.91 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DS3's stock price target?
Price Target
54.66
EUR
According to Wall Street analysts, the average 1-year price target for DS3 is 54.66 EUR with a low forecast of 38.88 EUR and a high forecast of 88.91 EUR.
What is the Revenue forecast for DocuSign Inc?
Projected CAGR
7%
Over the last 9 years, the compound annual growth rate for Revenue has been 27%. The projected CAGR for the next 8 years is 7%.
What is the Operating Income forecast for DocuSign Inc?
Projected CAGR
60%
The compound annual growth rate for Operating Income over the next 3 years is 60%.
What is the Net Income forecast for DocuSign Inc?
Projected CAGR
22%
The compound annual growth rate for Net Income over the next 8 years is 22%.
